Bifogade filer
Kurs
+4,13%
Likviditet
0,31 MDKK
Kalender
Est. tid* | ||
2025-11-06 | 09:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 09:00 | Kvartalsrapport 2025-Q2 |
2025-05-19 | N/A | X-dag ordinarie utdelning STENO 0.00 DKK |
2025-05-08 | 09:00 | Kvartalsrapport 2025-Q1 |
2025-02-27 | - | Bokslutskommuniké 2024 |
2024-12-18 | - | Extra Bolagsstämma 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-16 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2024-05-15 | - | Årsstämma |
2024-05-02 | - | Kvartalsrapport 2024-Q1 |
2024-02-22 | - | Bokslutskommuniké 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-06-20 | - | Kvartalsrapport 2023-Q1 |
2023-06-13 | - | Extra Bolagsstämma 2023 |
2023-05-22 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2023-02-23 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Extra Bolagsstämma 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-18 | - | Kvartalsrapport 2022-Q2 |
2022-05-20 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2022-05-19 | - | Årsstämma |
2022-05-05 | - | Kvartalsrapport 2022-Q1 |
2022-02-24 | - | Bokslutskommuniké 2021 |
2021-11-04 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2021-05-20 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-11-05 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
2020-05-14 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-26 | - | Bokslutskommuniké 2019 |
2019-11-06 | - | Kvartalsrapport 2019-Q3 |
2019-08-20 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | Kvartalsrapport 2019-Q1 |
2019-02-21 | - | Bokslutskommuniké 2018 |
Beskrivning
Land | Danmark |
---|---|
Lista | First North Denmark |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("Stenocare") announced October 14, 2022, that it had received approval to supply a new CBD 20 mg/mL medical cannabis oil product to the Danish Pilot Programme. With this new product, Stenocare is the only supplier of CBD oil products under the Pilot Programme and the new products are officially ready for sales across the entire country as of today.
Sales can begin: STENOCARE has completed the import of the new medical cannabis oil product into Denmark. The new product is a CBD oil containing 20 mg/mL with dosing delivered via an oral syringe. The new product is available via pharmacies and requires a prescription from a doctor.
Stenocare is the first and so far, only supplier of oil based medical cannabis products for the Danish Pilot Programme with a portfolio of two medical cannabis oil products (ie. THC30 oil and CBD20 oil) from the GMP certified Canadian supplier, AgMEDICA Bioscience.
Stenocare CEO Thomas Skovlund Schnegelsberg comments:
"We are starting the new year with an important milestone. We have delivered the first CBD oil product batch to the Danish market, and our sales can begin. It has been a year of hard work for our regulatory team to reach this important milestone and therefore our team can be extra proud with our delivery today."
Thomas Skovlund Schnegelsberg, CEO Phone: +45 31770060 E-mail: presse@stenocare.com